Transcription of listed. - CINVANTI
{{id}} {{{paragraph}}}
Example: bankruptcy
listed. - CINVANTI
1 HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CINVANTITM safely and effectively. See full prescribing information for CINVANTI . CINVANTITM ( aprepitant) injectable emulsion, for intravenous use Initial Approval: 2003 ----------------------------INDICATIONS AND USAGE---------------------------- CINVANTI is a substance P/neurokinin-1 (NK 1) receptor antagonist, indicated in adults, in combination with other antiemetic agents, for the prevention of: acute and delayed nausea and vomiting associated with initial and repeatcourses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin. (1) nausea and vomiting associated with initial and repeat courses ofmoderately emetogenic cancer chemotherapy (MEC).
Nov 09, 2017 · 2 . FULL PRESCRIBING INFORMATION . 1 INDICATIONS AND USAGE CINVANTI, in combination with other antiemetic agents, is indicated in adults for the prevention of:
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: